September 26, 2023 01:14 PM EDTUpdated September 27, 10:47 AM

MarketingRx roundup: Pharma industry rep drops in Gallup poll; Pfizer website reveals not-yet-approved drug name

Beth Snyder Bulik

Senior Editor

Has the Covid-19 pandemic goodwill halo for the pharma industry worn off? The latest US Gallup annual business sector poll shows it is slipping with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

MarketingRx roundup: Pharma industry rep drops in Gallup poll; Pfizer website reveals not-yet-approved drug name

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Mar­ket­ingRx roundup: Phar­ma in­dus­try rep drops in Gallup poll; Pfiz­er web­site re­veals not-yet-ap­proved drug name

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

MarketingRx roundup: Pharma industry rep drops in Gallup poll; Pfizer website reveals not-yet-approved drug name